-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Cyteir Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2022.
- Cyteir Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$3.53M, a 68% increase year-over-year.
- Cyteir Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$33.2M, a 32.3% increase year-over-year.
- Cyteir Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$46.1M, a 9.34% decline from 2021.
- Cyteir Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$42.1M, a 102% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)